Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil + propofol general anesthesia versus neuraxial anesthesia for elective cesarean delivery in placenta previa
ChiCTR2600133985Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jul 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil and propofol in placenta previa (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: NICU admission rate. Started Jul 2026; status: recruiting.
02
Drugs
remifentanilpropofol
03
Conditions
placenta previa
Beyond the preview
Go deeper on ChiCTR2600133985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133985.